Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Adaptive Biotechnologies Corporation Common Stock (ADPT)

Biological Products, (no Disgnostic Substances)

https://www.adaptivebiotech.com

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease ("MRD") in patients with multiple myeloma ("MM"), B cell acute lymphoblastic leukemia ("ALL") and chronic lymphocytic leukemia ("CLL") and is also available as a CLIA-validated laboratory developed test ("LDT") for patients with other lymphoid cancers, including diffuse large B-cell lymphoma ("DLBCL").

1165 EASTLAKE AVE E
SEATTLE, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/27/2019

Market Cap

709,517,286

Shares Outstanding

144,770,000

Weighted SO

144,772,751

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

VERV --.--%

BEAM --.--%

CRBU --.--%

SANA --.--%

VECT --.--%

KNTE --.--%

RPRX --.--%

IKNA --.--%

CWBR --.--%

Beta

1.3460

Last Div

0.0000

Range

2.28-6.96

Chg

-0.1188

Avg Vol

1473375

Mkt Cap

709517286

Exch

NASDAQ

Country

US

Phone

206 659 0067

DCF Diff

0.0402

DCF

9.3198

Div Yield

0.0000

P/S

4.2041

EV Multiple

-5.3101

P/FV

2.9356

Div Yield %

0.0000

P/E

-3.3224

PEG

-0.1573

Payout

0.0000

Current Ratio

3.9892

Quick Ratio

3.8393

Cash Ratio

0.6788

DSO

79.6111

DIO

57.0735

Op Cycle

136.6846

DPO

42.6172

CCC

94.0674

Gross Margin

0.4993

Op Margin

-1.0949

Pretax Margin

-1.2653

Net Margin

-1.2649

Eff Tax Rate

0.0076

ROA

-0.3650

ROE

-0.7196

ROCE

-0.3720

NI/EBT

0.9996

EBT/EBIT

1.1556

EBIT/Rev

-1.0949

Debt Ratio

0.2426

D/E

0.5873

LT Debt/Cap

0.3535

Total Debt/Cap

0.3700

Int Coverage

538.7464

CF/Debt

-0.9111

Equity Multi

2.4208

Rec Turnover

4.5848

Pay Turnover

8.5646

Inv Turnover

6.3953

FA Turnover

1.6237

Asset Turnover

0.2886

OCF/Share

-0.8769

FCF/Share

-0.9266

Cash/Share

1.9800

OCF/Sales

-0.7660

FCF/OCF

1.0566

CF Coverage

-0.9111

ST Coverage

-13.1829

CapEx Coverage

-17.6698

Div&CapEx Cov

-17.6698

P/BV

2.9356

P/B

2.9356

P/S

4.2041

P/E

-3.3224

P/FCF

-5.1946

P/OCF

-5.4864

P/CF

-5.4864

PEG

-0.1573

P/S

4.2041

EV Multiple

-5.3101

P/FV

2.9356

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 07, 23:30 Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions Benzinga Jul 02, 02:19 Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor GlobeNewswire Inc. Dec 27, 16:05 Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. Dec 27, 16:05 Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference Benzinga Dec 12, 23:22 Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam Benzinga Dec 12, 23:22 Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam Benzinga Dec 12, 23:22 Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam The Motley Fool Dec 12, 05:50 Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You? Benzinga Dec 11, 22:55 Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails Benzinga Dec 11, 22:55 Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails Benzinga Dec 11, 22:55 Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails Benzinga Dec 11, 22:55 Cathie Wood's Ark Dumps $12.8M Worth Of Grayscale Bitcoin Trust Amid Crypto Rally Losing Wind In Sails GlobeNewswire Inc. Dec 09, 08:30 Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting GlobeNewswire Inc. Dec 09, 08:30 Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting GlobeNewswire Inc. Dec 09, 08:30 Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting GlobeNewswire Inc. Dec 05, 07:30 Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting GlobeNewswire Inc. Nov 07, 07:30 Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline Benzinga Oct 24, 11:00 Expert Ratings for Adaptive Biotechnologies

Revenue Product Segmentation